WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 692
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 902

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 2'204  2'175  2'146  2'117  2'090  1'869  1'604  1'310 
Births 61  61  61  60  60  59  57  54 
Surviving infants 58  58  58  57  56  54  53  48 
Pop. less than 5 years 286  280  276  272  267  272  255  225 
Pop. less than 15 years 783  775  771  767  764  771  707  582 
Female 15-49 years 586  576  565  553  542  461  368  317 

Number of reported cases

(Click for retrospective incidence data for Lesotho)
Diphtheria
ChartChart
  37  13 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  516  179  660  2'195  7'935 
Mumps
ChartChart
 
Pertussis
ChartChart
  34  2'020 
Polio*
ChartChart
  36 
Rubella
ChartChart
  11  129  296  516  68 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  27 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Lesotho)
Vaccine year result method % card seen                                                
BCG 2013  98  DHS   77  68  73  51  65  68  73 
DTP1 2013  98  DHS   77  70  69  71  69  69 
DTP3 2013  85  DHS   77  67  67  69  66  67  69  71 
DTP4         
IPV1          44 
HepB_BD         
HepB3 2011  95  EPI   92  67  67  69  66  67 
Hib3 2013  85  DHS   77  67  67  69  66  67 
JapEnc         
MCV1          60  66  58  61  60  80 
MCV2          49  66  54 
MenA         
PCV1          68  99* 
PCV2          68  90 
PCV3          66  62 
Pol3 2013  76  DHS   77  65  65  67  66  66  67  73 
Rota1         
RotaC         
RCV1         
TT2plus 2013  58  DHS   77  68  68  47  39  36 
PAB         
VAD1          47  13 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Lesotho)
BCG
ChartChart
  98  98  98  98  93  88  89  81 
DTP1
ChartChart
  98  98  98  98  98  87  91  75 
DTP3
ChartChart
  93  93  93  93  95  83  82  56 
HepB3
ChartChart
  93  93  93  93  95 
HepB_BD
ChartChart
 
Hib3
ChartChart
  93  93  93  93  95 
IPV1
  44 
MCV1
ChartChart
  90  90  90  90  91  74  80  49 
MCV2
ChartChart
  82  82  82  82  82 
PCV3
ChartChart
  93  29 
Pol3
ChartChart
  90  90  90  90  93  82  82  56 
RCV1
 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 10  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 10
From 50 to 79% 80
Less than 50% 10
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 18 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus From July 2017
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2017  2012-2017  2012-2017  2012-2016  2012-2016  2012-2016  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 10  10  10 

System performance

Total Nº districts in country number 10  10  10  10  10  10  10 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 10  20  10  10  20 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100%

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  No  No  No  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 92  31  99  54    47   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.